相关实验视频
Updated: Sep 14, 2025

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
9.2K
在发作和缓解期间的MRI特征区分了MOG抗体相关疾病患者和多发性硬化症患者
Stephanie B Syc-Mazurek1, Laura Cacciaguerra1,2, Deena A Tajfirouz3
1Neurology and Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Journal of neurology, neurosurgery, and psychiatry
|July 20, 2025
概括
髓寡细胞糖蛋白抗体相关疾病 (MOGAD) 和多发性硬化症 (MS) 呈现出明显的MRI特征. 缓解MRI扫描,特别是T2损伤分辨率,有助于区分MOGAD和MS,帮助诊断.
科学领域:
- 神经免疫学 神经免疫学
- 放射学 放射学是一门学科.
- 神经学 神经学
背景情况:
- 髓寡细胞糖蛋白抗体相关性疾病 (MOGAD) 和多发性硬化症 (MS) 具有重叠但独特的MRI病变特征.
- 这些成像特征可以根据MRI相对于疾病活动的获取时间而有很大差异.
研究的目的:
- 为了确定MOGAD和MS之间的MRI特征区分.
- 为了比较在临床攻击和缓解阶段获得的配对MRI扫描.
主要方法:
- 梅奥诊所诊断出MOGAD或MS的患者的回顾性分析.
- 纳入标准要求满足诊断标准,并可获得配对发作 (≤30天) 和缓解 (≥12个月) 的MRI扫描,没有间隔发作.
- 在MOGAD和MS组之间对MRI关键特征的比较分析.
主要成果:
- 至少一个T2损伤的分辨率是MOGAD和MS之间的关键差异化因素 (90%的尤登指数).
- 与MS患者相比,MOGAD患者的正常随访MRI扫描的可能性更高 (p<0.001).
- 特殊的病变特征,如T1低强度,卵状周周结膜T2和增强病变在MS中更为频繁,而纵向广泛的T2病变在MOGAD发作中更为常见.
结论:
- 攻击和缓解时的配对MRI扫描显示了区分MOGAD和MS的独特特征.
- 在缓解期间T2损伤的解决提供了显著的诊断价值来区分MOGAD和MS.
- 一年后的MRI可以帮助诊断MOGAD,特别是在初始关节细胞参与的情况下,并建立一个新的基线.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Magnetic Resonance Imaging
7.1K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.1K

